LO FRANCIS sold $2.4M of ADPT
LO FRANCIS (Chief People Officer) sold 105,762 shares of Adaptive Biotechnologies Corp (ADPT) at $22.59 ($2.39M total) on 2026-07-15 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on insider trading activity but does not introduce new company-specific fundamentals or guidance.
Market read
Traders may note insider selling activity, but the 10b5-1 designation reduces interpretive weight.
What to watch
Insider sales can be offset by other insider purchases or broader company catalysts not mentioned here; this filing alone does not establish directionality for future performance.
Background
The article is an SEC Form 4 insider transaction disclosure for Adaptive Biotechnologies (ADPT).
Ticker impact
SEC Form 4 shows Adaptive Biotechnologies insider Lo Francis sold 105,762 shares at $22.59 on 2026-07-15 under a 10b5-1 plan.
Likely minimal near-term price impact; any effect is more about sentiment than new company information.
The filing is a primary-source Form 4, but it discloses no new operational, financial, or regulatory development, and explicitly notes a pre-arranged 10b5-1 plan.
Market effects
No clear read-across to biotech sector fundamentals from a single insider sale.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.
Key entities
- issuerAdaptive Biotechnologies Corp
Subject of the Form 4 insider transaction disclosure.
- insiderLo Francis
Chief People Officer who sold shares.
